51³Ô¹Ïapp
Back to

Professor Andrew Carr

Conjoint Professor
Medicine & Health
School of Clinical Medicine
Phone
8382 3359
E-mail
acarr@stvincents.com.au
  • Book Chapters | 2004
    Mallon PWG; Cooper DA; Carr A, 2004, 'Chapter 33 Toxicities of Antiretroviral Therapy', in AIDS and Other Manifestations of HIV Infection, Elsevier, pp. 867 - 882,
    Book Chapters | 2004
    Mallon PWG; Cooper DA; Carr A, 2004, 'Toxicities of Antiretroviral Therapy', in AIDS and Other Manifestations of HIV Infection, pp. 867 - 882,
    Book Chapters | 2000
    Carr AD; Cooper DA, 2000, 'Primary HIV infection', in AIDS Pathogenesis, Kluwer Academic Publishers, Netherlands, pp. 19 - 40
    Book Chapters | 1999
    Carr AD; Cooper DA, 1999, 'Primary HIV infection', in The Medical Management of AIDS, W B Saunders Company, Pennsylvania, pp. 67 - 78
  • Journal articles | 2024
    James F; Goh MS; Vogrin S; Ng I; Douglas AP; Holmes NE; Chua KY; De Luca J; Sharma P; Zubrinich C; Aung AK; Gin D; Lambros B; Baker C; Foley P; Chong AH; Thien F; Fok JS; Su J; Scardamaglia L; Awad A; Tong S; Johnson D; Godsell J; Arasu A; Barnes S; Ojaimi S; Mar A; Yun J; Ange N; Tong WWY; Carr A; Loprete J; Katelaris CH; Slape D; Keat K; West TA; Lee M; Smith W; Hissaria P; Sidhu S; Janson S; Venkatesan S; Davies J; Lane MJ; Redmond AM; Robertson I; Legg A; Fernando S; Boyle T; Li J; Phillips EJ; Cleland H; Kern JS; Trubiano JA, 2024, 'The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions', World Allergy Organization Journal, 17,
    Journal articles | 2024
    Loprete J; Montemayor J; Bramah V; McEwan C; Richardson R; Green J; Carr A; Tong W, 2024, 'Predictors of severe and recurrent adult anaphylaxis, and gaps in the cascade of care: a retrospective, single-centre study 2009–2018', Internal Medicine Journal, 54, pp. 265 - 273,
    Journal articles | 2024
    Loprete J; Montemayor J; Richardson R; Rogers J; Tong W; Carr A, 2024, 'Peanut oral immunotherapy plus omalizumab for 24 weeks safely induced tolerance at 48 weeks in allergic adults', Journal of Allergy and Clinical Immunology, 153, pp. AB126 - AB126,
    Journal articles | 2024
    Mills AM; Rizzardini G; Ramgopal MN; Osiyemi OO; Bogner JR; Hagins DP; Paredes R; Reynes J; Rockstroh JK; Carr A; Su FH; Klopfer SO; Eves K; Plank RM; Correll T; Fox MC, 2024, 'Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial', The Lancet HIV, 11, pp. e357 - e368,
    Journal articles | 2024
    Pathmanandavel K; Jackson K; Le S; Alves M; Foley E; Tangye S; Ma C; Deenick E; Tong W; Carr A; Breit S; Sewell W; Kane A, 2024, 'Mucosal-associated invariant T (MAIT) cells exhibit restricted T cell receptor β constant region usage, obfuscating assessment of T cell clonality', Pathology, 56, pp. S114 - S114,
    Journal articles | 2024
    Pathmanandavel K; Le S; Xie S; Alves M; Foley E; Kelleher A; Zaunders J; Carr A; Tong W; Breit S; Sewell W; Kane A, 2024, 'Novel clinical applications of functional assays to measure antigen-specific cellular immunity', Pathology, 56, pp. S27 - S27,
    Journal articles | 2023
    Aung HL; Siefried KJ; Gates TM; Brew BJ; Mao L; Carr A; Cysique LA, 2023, 'Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not', eClinicalMedicine, 56, pp. 101792,
    Journal articles | 2023
    Callander D; McManus H; Gray RT; Grulich AE; Carr A; Hoy J; Donovan B; Fairley CK; Holt M; Templeton DJ; Liaw S-T; McMahon JM; Asselin J; Petoumenos K; Hellard M; Pedrana A; Elliott J; Keen P; Costello J; Keane R; Kaldor J; Stoové M; Guy R, 2023, 'HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study', The Lancet HIV,
    Journal articles | 2023
    Carr A; Mackie NE; Paredes R; Ruxrungtham K, 2023, 'HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective', Antiviral Therapy, 28,
    Journal articles | 2023
    Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE, 2023, 'Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', Clinical Infectious Diseases, 76, pp. E622 - E628,
    Journal articles | 2023
    Jaschinski N; Greenberg L; Neesgaard B; Miró JM; Grabmeier-Pfistershammer K; Wandeler G; Smith C; De Wit S; Wit F; Pelchen-Matthews A; Mussini C; Castagna A; Pradier C; D'Arminio Monforte A; Vehreschild J; Sönnerborg A; Anne AV; Carr A; Bansi-Matharu L; Lundgren J; Garges H; Rogatto F; Zangerle R; Günthard HF; Rasmussen LD; Nescoi C; Van Der Valk M; Menozzi M; Muccini C; Mocroft A; Peters L; Ryom L, 2023, 'Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV', AIDS, 37, pp. 467 - 475,
    Journal articles | 2023
    Loprete J; Richardson R; Bramah V; Comben S; Li T; Beiglari L; O'Neill R; McEwan C; Carr A; Tong W; Campbell D; Wong M; Evans L; Post J; Torda A; Kane A; Kelleher A; Wainstein B; McMullan B; Law M, 2023, 'Delabeling, safety, and impact of β-lactam allergy testing: A systematic review', Journal of Allergy and Clinical Immunology: Global, 2,
    Journal articles | 2023
    Wong J; Allwright M; Hruby G; Roberts JM; Carr A; Jin F; Gett R; Meagher AP; Hillman R, 2023, 'Anal cancer: a 20-year retrospective study from Australia', ANZ Journal of Surgery, 93, pp. 2697 - 2705,
    Journal articles | 2022
    Brazier E; Ajeh R; Maruri F; Musick B; Freeman A; Wester CW; Lee MP; Shamu T; Crabtree Ramírez B; d'Almeida M; Wools-Kaloustian K; Kumarasamy N; Althoff KN; Twizere C; Grinsztejn B; Tanser F; Messou E; Byakwaga H; Duda SN; Nash D; Chansilpa C; Dougherty T; Karminia A; Law M; Ross J; Sohn A; Aguirre I; Baker D; Bloch M; Cabot S; Carr A; Couldwell D; Edwards S; Eu B; Farlow H; Finlayson R; Gunathilake M; Hazlewood C; Hoy J; Langton-Lockton J; Le J; Leprince E; Minc A; Moore R; O'Sullivan M; Roth N; Rowling D; Russell D; Ryder N; Saunders C; Silvers J; Smith DJ; Sowden D; Sweeney G; Tan L; Teague R; Templeton D; Thng C; Woolley I; Khol V; Ly PS; Li TH; Po LM; Kinikar A; Kumarasamy N; Mundhe S; Pujari S; Sangle S; Nimkar S; Jassin M; Kurniati N; Merati TP; Muktiarti D; Amalia R; Sukmawati NMDD; Wati KDK; Yunihastuti E; Tanuma J; Choi JY; Azwa RISR; Cheng CK; Gani YM; Mohamed TJ; Moy FS; Nallusamy R; Nor MZM; Rudi N; Shyan WP; Yusoff NKN; Ditangco R; Chan YJ; Wu PC; Wu PF; Avihingsanon A; Chaiwarith R; Chokephaibulkit K; Khusuwan S; Kiertiburanakul S; Kosalaraksa P; Lumbiganon P, 2022, 'Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium', Journal of the International AIDS Society, 25,
    Journal articles | 2022
    Hernández Cordero AI; Yang CX; Yang J; Li X; Horvath S; Shaipanich T; MacIsaac J; Lin D; McEwen L; Kobor MS; Guillemi S; Harris M; Lam W; Lam S; Obeidat M; Novak RM; Hudson F; Klinker H; Dharan N; Montaner J; Man SFP; Kunisaki K; Sin DD; Leung JM; Baker JV; Duprez D; Carr A; Hoy J; Dolan M; Telenti A; Grady C; Matthews G; Rockstroh J; Belloso WH; Kagan JM; Wright E; Brew B; Price RW; Robertson K; Cysique L; Connett JE; Niewoehner DE; Endpoint Review Committee ; Lifson A; Davey RT; Gatell JM; Pedersen C; Prineas R; Worley J, 2022, 'The relationship between the epigenetic aging biomarker “grimage†and lung function in both the airway and blood of people living with HIV: An observational cohort study', eBioMedicine, 83,
    Journal articles | 2022
    James F; Goh MSY; Mouhtouris E; Vogrin S; Chua KYL; Holmes NE; Awad A; Copaescu AM; De Luca JF; Zubrinich C; Gin D; Cleland H; Douglas A; Kern JS; Katelaris CH; Thien F; Barnes S; Yun J; Tong W; Smith WB; Carr A; Anderson T; Legg A; Bourke J; MacKay LK; Aung AK; Phillips EJ; Trubiano J, 2022, 'Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)', BMJ Open, 12,
    Journal articles | 2022
    Loprete J; Katelaris CH; Evans L; Kane A; McMullan B; Wainstein B; Wong M; Post J; Suan D; Swaminathan S; Richardson R; Rogers J; Torda A; Campbell DE; Kelleher AD; Law M; Carr A; Tong WWY, 2022, 'Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study', Journal of Allergy and Clinical Immunology: Global, 1, pp. 99 - 105,
    Journal articles | 2022
    Neesgaard B; Greenberg L; Miró JM; Grabmeier-Pfistershammer K; Wandeler G; Smith C; De Wit S; Wit F; Pelchen-Matthews A; Mussini C; Castagna A; Pradier C; d'Arminio Monforte A; Vehreschild JJ; Sönnerborg A; Anne AV; Carr A; Bansi-Matharu L; Lundgren JD; Garges H; Rogatto F; Zangerle R; Günthard HF; Rasmussen LD; Necsoi C; van der Valk M; Menozzi M; Muccini C; Peters L; Mocroft A; Ryom L, 2022, 'Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium', The Lancet HIV, 9, pp. e474 - e485,
    Journal articles | 2022
    Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209,
    Journal articles | 2022
    Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2022, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men (vol 72, pg 853, 2021)', CLINICAL INFECTIOUS DISEASES, 74,
    Journal articles | 2021
    Chan C; Fraser D; Vaccher S; Yeung B; Jin F; Amin J; Dharan NJ; Carr A; Ooi C; Vaughan M; Holden J; Power C; Grulich AE; Bavinton BR, 2021, 'Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: Results from the MI-EPIC clinical trial', Sexual Health, 18, pp. 453 - 459,
    Journal articles | 2021
    Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried KJ; Lintzeris N, 2021, 'Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: A phase-2 dose-escalation study', BMJ Open, 11, pp. e044696,
    Journal articles | 2021
    Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, 8, pp. e486 - e494,
    Journal articles | 2021
    McManus H; Callander D; Asselin J; McMahon J; Hoy JF; Templeton DJ; Fairley CK; Donovan B; Pedrana AE; Keen P; Wilson DP; Elliott J; Kaldor J; Liaw ST; Petoumenos K; Holt M; Hellard ME; Grulich AE; Carr A; Stoove MA; Guy RJ, 2021, 'A New Method for Estimating the Incidence of Infectious Diseases', American Journal of Epidemiology, 190, pp. 1386 - 1395,
    Journal articles | 2021
    Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; MacHalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2021, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men', Clinical Infectious Diseases, 72, pp. 853 - 861,
    Journal articles | 2021
    van Santen DK; Asselin J; Haber NA; Traeger MW; Callander D; Donovan B; El-Hayek C; McMahon JH; Petoumenos K; McManus H; Hoy JF; Hellard M; Guy R; Stoové M; Carr A; Elliot J; Templeton DJ; Liaw T; Wilson DP, 2021, 'Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012–19): a longitudinal cohort study', The Lancet HIV, 8, pp. e623 - e632,
    Journal articles | 2020
    Calon M; Menon K; Carr A; Henry RG; Rae CD; Brew BJ; Cysique LA, 2020, 'Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV', Journal of Acquired Immune Deficiency Syndromes, 84, pp. 543 - 551,
    Journal articles | 2020
    Carr A; Grund B; Schwartz AV; Avihingsanon A; Badal-Faesen S; Bernadino JI; Estrada V; La Rosa A; Mallon PWG; Pujari S; White D; Wyman Engen N; Ensrud K; Hoy JF, 2020, 'The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy', HIV Medicine, 21, pp. 64 - 70,
    Journal articles | 2020
    Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Farnsworth A; Biro C; Richards A; Thurloe J; Ekman D; McDonald R; Adams M; Tabrizi S; Phillips S; Luque MM; Comben S; McCaffery K; Howard K; Kelly P; Seeds D; Carr A; Feeney L; Gluyas R; Prestage G; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P; Varma R; Langton-Lockton J; Tong W; Han A, 2020, 'Prevalence and association of perianal and intra-anal warts with composite high-grade squamous intraepithelial lesions among gay and bisexual men: Baseline data from the study of the prevention of anal cancer', AIDS Patient Care and STDs, 34, pp. 436 - 443,
    Journal articles | 2019
    Carr A; Kerr SJ; Richardson R; Ebeling P; Pocock N; Rojas J; Martinez E; Hoy J, 2019, 'Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study', Journal of Bone and Mineral Research, 34, pp. 2192 - 2197,
    Journal articles | 2019
    Carr A; Richardson R; Liu Z, 2019, 'Success and failure of initial antiretroviral therapy in adults: An updated systematic review', AIDS, 33, pp. 443 - 453,
    Journal articles | 2019
    Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Prestage G; Tong W; Carr A; Varma R, 2019, 'Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC)', Cancer Epidemiology, 58, pp. 12 - 16,
    Journal articles | 2018
    Hoy JF; Richardson R; Ebeling PR; Rojas J; Pocock N; Kerr SJ; Martinez E; Carr A, 2018, 'Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV', AIDS, 32, pp. 1967 - 1975,
    Journal articles | 2018
    McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years', AIDS, 32, pp. 451 - 459,
    Journal articles | 2018
    McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.', AIDS, 32, pp. 451 - 459,
    Journal articles | 2018
    Orkin C; Llibre JM; Gallien S; Antinori A; Behrens GMN; Carr A, 2018, 'Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence', HIV Medicine, 19, pp. 18 - 32,
    Journal articles | 2018
    Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; De Wit J; Carr A, 2018, 'Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy', AIDS, 32, pp. 35 - 48,
    Journal articles | 2017
    Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, 33, pp. 648 - 657,
    Journal articles | 2017
    Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A, 2017, 'Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial', Journal of Bone and Mineral Research, 32, pp. 1945 - 1955,
    Journal articles | 2017
    Jin F; Roberts JM; Grulich AE; Poynten IM; MacHalek DA; Cornall A; Phillips S; Ekman D; McDonald RL; Hillman RJ; Templeton DJ; Farnsworth A; Garland SM; Fairley CK; Tabrizi SN; Law C; Biro C; Richards A; Thurloe J; Adams M; McCaffery K; Howard K; Kelly P; Seeds D; Garcia M; Carr A; Feeney L; Gluyas R; Prestage G; Petoumenos K; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P, 2017, 'The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men', AIDS, 31, pp. 1303 - 1311,
    Journal articles | 2017
    McAllister JW; Towns JM; McNulty A; Pierce AB; Foster R; Richardson R; Carr A, 2017, 'Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men', AIDS, 31, pp. 1291 - 1295,
    Journal articles | 2017
    Poynten IM; Tabrizi SN; Jin F; Templeton DJ; Machalek DA; Cornall A; Phillips S; Fairley CK; Garland SM; Law C; Carr A; Hillman RJ; Grulich AE, 2017, 'Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men', Papillomavirus Research, 3, pp. 80 - 84,
    Journal articles | 2017
    Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703,
    Journal articles | 2017
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; De Wit J; Carr A, 2017, 'Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression', PLoS ONE, 12, pp. e0174613,
    Journal articles | 2017
    Templeton DJ; Roberts JM; Poynten IM; Law C; Hillman RJ; Farnsworth A; Fairley CK; Tabrizi SN; Garland SM; Grulich AE; Jin F; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley K; Feeney L; Fraissard E; Howard K; Law M; MacHalek D; McCaffery K; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2017, 'Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)', European Journal of Cancer Prevention, 26, pp. 212 - 216,
    Journal articles | 2016
    Callander D; Stoové M; Carr A; Hoy JF; Petoumenos K; Hellard M; Elliot J; Templeton DJ; Liaw S; Wilson DP; Grulich A; Cooper DA; Pedrana A; Donovan B; McMahon J; Prestage G; Holt M; Fairley CK; McKellar-Stewart N; Ruth S; Asselin J; Keen P; Cooper C; Allan B; Kaldor JM; Guy R; Cooper D; Liaw T, 2016, 'A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: The Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol', BMC Infectious Diseases, 16, pp. 752,
    Journal articles | 2016
    Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, 22, pp. 56 - 65,
    Journal articles | 2016
    Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N, 2016, 'Study protocol: A dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence', BMC Psychiatry, 16,
    Journal articles | 2016
    Ezard N; Dunlop AJ; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N, 2016, 'LISDEX I: DOSE-ESCALATING, PHASE-2 STUDY OF ORAL LISDEXAMFETAMINE IN ADULTS WITH METHAMPHETAMINE DEPENDENCE', DRUG AND ALCOHOL REVIEW, 35, pp. 36 - 36,
    Journal articles | 2016
    Hillman RJ; Gunathilake MPW; Jin F; Tong W; Field A; Carr A, 2016, 'Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time', Sexual Health, 13, pp. 177 - 181,
    Journal articles | 2016
    Lee FJ; Marriott D; Bloch M; Richardson R; Mackenzie N; Carr A, 2016, 'Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART', Journal of Antimicrobial Chemotherapy, 71, pp. 1127 - 1129,
    Journal articles | 2016
    Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A, 2016, 'Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial', HIV Medicine, 17, pp. 605 - 614,
    Journal articles | 2016
    Machalek DA; Jin F; Poynten IM; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men', Papillomavirus Research, 2, pp. 97 - 105,
    Journal articles | 2016
    O'Dwyer EJ; Bhamra-Ariza P; Rao S; Emmanuel S; Carr A; Holloway CJ, 2016, 'Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome', Open Heart, 3,
    Journal articles | 2016
    Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Reiss P; van Sighem AI; Nelson M; Montaner JSG; Lane HC; Larder BA; Harrigan R; de Wit TR; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Kaiser R; Schuelter E; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Pozniak A; Mandalia S; Webster D; Smith C; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias MJ; Vella S; Dettorre G; Carr A; Norris R; Hesse K; Vlahakis E; Barth R; Hoffmann C; Ene L; Dragovic G; Diaz R; Sucupira C; Sued O; Cesar C; Madero JS; Emery S; Cooper D; Baxter J; Monno L; Picchio G; deBethune MP; Khabo P; Ledwaba L, 2016, 'An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype', Journal of Antimicrobial Chemotherapy, 71, pp. 2928 - 2937,
    Journal articles | 2016
    Roberts JM; Jin F; Thurloe JK; Ekman D; Adams MK; McDonald RL; Biro C; Poynten IM; Grulich AE; Farnsworth A; Aarnsworth R; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley C; Farnsworth A; Feeney L; Garcia M; Garland S; Gluyas R; Hillman R; Howard K; Lawa F; Law C; Law M; Machalek D; McCaffery K; McGrath P; Mellor R; Pendlebury S; Petoumenos K; Pezzopane P; Phillips S; Mary Poynten I; Prestage G; Richards A; Seeds D; Segelov E; Tabrizi S; Templeton D; Tong W; Varma R, 2016, 'The value of a transformation zone component in anal cytology to detect HSIL', Cancer Cytopathology, 124, pp. 596 - 601,
    Journal articles | 2016
    Stellbrink HJ; Le Fevre E; Carr A; Saag MS; Mukwaya G; Nozza S; Valluri SR; Vourvahis M; Rinehart AR; McFadyen L; Fichtenbaum C; Clark A; Craig C; Fang AF; Heera J, 2016, 'Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment', AIDS, 30, pp. 1229 - 1238,
    Journal articles | 2016
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; Carr A; Cheung C; Foster R; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; Murphy D; Ooi C; Pell C; Ryder N; De Wit J; Wright E, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, 6, pp. e012179corr1,
    Journal articles | 2015
    Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino J; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J, 2015, 'Prevalence of and risk factors for low bone mineral density in untreated HIV infection: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 137 - 146,
    Journal articles | 2015
    Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology,
    Journal articles | 2015
    Foster R; McAllister J; Read TR; Pierce AB; Richardson R; McNulty A; Carr A, 2015, 'Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex with Men', Clinical Infectious Diseases, 61, pp. 1336 - 1341,
    Journal articles | 2015
    Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, 16, pp. 152 - 160,
    Journal articles | 2015
    James K; Al-Ali S; Tarn J; Cockell SJ; Gillespie CS; Hindmarsh V; Locke J; Mitchell S; Lendrem D; Bowman S; Price E; Pease CT; Emery P; Lanyon P; Hunter JA; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Hall F; Bacabac EC; Chadravarty K; Lamabadusuriya S; Adeniba R; Hamburger J; Richards A; Rauz S; Brailsford S; Logan J; Mulherin D; Andrews J; McManus A; Booth A; Dimitroulas T; Kadiki L; Kaur D; Kitas G; Lloyd M; Moore L; Gordon E; Lawson C; Stirton L; Ortiz G; Clunie G; Rose G; Cuckow S; Knight S; Symmons D; Jones B; Carr A; Collins K; Corbett I; Downie C; Edgar S; Carrozzo M; Figuereido F; Foggo H; Hackett K; Macleod I; Mawson P; Natasari A; Stocks P; Jones A; Muir A; White P; Pugmire S; Watkins M; Field A; Kaye S; Mewar D; Medcalf P; Tomlinson P; Whiteside D; Pauling J; James J; Olaitan N; McDermott J; Godia O; Kidd E; Palmer L; Katsande V; Long P; Li C; Chandra U; MacKay K; Fedele S, 2015, 'A transcriptional signature of fatigue derived from patients with primary Sjögren's syndrome', PLoS ONE, 10,
    Journal articles | 2015
    Langton-Lockton J; Hesse K; Carr A; Field AS; Hillman RJ, 2015, 'P10.04 A new paradigm for follow-up of men with anal squamous cell cancer (ascc)', Sexually Transmitted Infections, 91, pp. A166.1 - A166,
    Journal articles | 2015
    Lee FJ; Amin J; Carr A, 2015, 'Limited reporting of major harms in studies of initial combination antiretroviral therapy: A systematic review', AIDS, 29, pp. 921 - 929,
    Journal articles | 2015
    Lee FJ; Carr A, 2015, 'Dyslipidemia in hiv-infected patients', , pp. 155 - 176,
    Journal articles | 2015
    McManus H; Petoumenos K; Brown K; Baker D; Russell D; Read T; Smith D; Wray L; Giles M; Hoy J; Carr A; Law MG; Australian HIV Observational Database , 2015, 'Loss to follow-up in the Australian HIV Observational Database', Antiviral Therapy, 20, pp. 731 - 741,
    Journal articles | 2015
    Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J; Finlayson R; Cooper D; Carr A; Bloch M; Harrod M; Pett S; Petoumenos K; Gold J; Medland N; Sullivan J; Han A, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, 12, pp. e1001809,
    Journal articles | 2015
    Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C; Bloch M; Cooper D; Konecny P; Carr A; Medland N; Sullivan J; Han A, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, 10, pp. e0139981,
    Journal articles | 2015
    Roberts JM; Jin F; Thurloe JK; Biro C; Poynten IM; Tabrizi SN; Fairley CK; Templeton DJ; Carr AD; Garland SM; Hillman RJ; Cornall AM; Grulich AE; Farnsworth A, 2015, 'High reproducibility of histological diagnosis of human papillomavirus-related intraepithelial lesions of the anal canal', Pathology, 47, pp. 308 - 313,
    Journal articles | 2015
    Sasson SC; McGill K; Wienholt L; Carr A; Brown D; Kelleher AD; Breit SN; Sewell WA, 2015, 'Retrospective audit of the freeliteTM serum free light chain (SFLC) assay: testing patterns, concordance with serum and urine electrophoresis/immunofixation and correlation with the N latex FLC assay', Pathology, 47, pp. S94 - S94,
    Journal articles | 2015
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, 47, pp. 564 - 569,
    Journal articles | 2015
    Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; NRoth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K; Cooper D; Han A, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, 15, pp. 326,
    Journal articles | 2015
    Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, 211, pp. 405 - 415,
    Journal articles | 2015
    Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions', Sexually Transmitted Infections, 91, pp. A168.2 - A168,
    Journal articles | 2015
    Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Roth N; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ; Han A, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, 18, pp. 19463,
    Journal articles | 2014
    Bloch M; Tong W; Hoy J; Baker D; Lee F; Richardson R; Carr A, 2014, 'Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks', HIV Medicine, 15, pp. 373 - 380,
    Journal articles | 2014
    Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, 20, pp. 258 - 268,
    Journal articles | 2014
    Duda SN; Farr AM; Lindegren ML; Blevins M; Wester CW; Wools-Kaloustian K; Ekouevi DK; Egger M; Hemingway-Foday J; Cooper DA; Moore RD; McGowan CC; Nash D; Saphonn V; Saramony S; Han N; Lee MP; Zhang F; Bele V; Pujari S; Merati T; Ramadian O; Yuliana F; Yunihastuti E; Oka S; Takano M; Kajindran A; Kamarulzaman A; Low LL; Sim BLH; Capistrano R; Ditangco R; Kuo LH; Wong WW; Chaiwarith R; Khongpattanayothin M; Kiertiburanakul S; Kotarathititum W; Phanuphak P; Piyavong B; Fou E; Ng OT; Choi JY; Han SH; Carr A; Chuah J; Dickson B; Hoy J; Ji J; Norris R; Templeton D; Watson K; Bendall C; Jiamsakul A; Law MG; McManus H; Durier N; Petersen B; Sohn AH; Rodriguez B; Gill MJ; Saag MS; Mugavero MJ; Willig J; Eron JJ; Napravnik S; Kitahata MM; Crane HM; Drozd DR; Sterling TR; Haas D; Bebawy S; Turner M; Gange SJ; Althoff KN; McKaig RG; Justice AC; Freeman AM; Lent C; Van Rompaey SE; Morton L; McReynolds J; Lober WB; Abraham AG; Lau B; Zhang J; Jing Y; Golub E; Modur S; Wong C; Mendes A; Masys DR; Minor B; Wehbe F; Cahn P; Krolewiecki A; Cesar C; Schechter M; Faulhaber JC; Wolff M, 2014, 'Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: Results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration', Journal of the International AIDS Society, 17,
    Journal articles | 2014
    Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A; Post J; Medland N; Boyd M, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e94858,
    Journal articles | 2014
    Lee FJ; Amin J; Carr A, 2014, 'Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: A systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up', PLoS ONE, 9,
    Journal articles | 2014
    Lee FJ; Tong WWY; Richardson R; Mackenzie N; Carr A, 2014, 'Metabolic effects of ritonavir-boosted atazanavir and darunavir in HIV-negative adults: A randomised comparison', Journal of AIDS and Clinical Research, 5,
    Journal articles | 2014
    Mcallister J; Read P; Mcnulty A; Tong W; Ingersoll A; Carr A, 2014, 'Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: Safety, tolerability and adherence', HIV Medicine, 15, pp. 13 - 22,
    Journal articles | 2014
    Peacock A; Bruno R; Martin FH; Carr A, 2014, 'Self-reported physiological and psychological side-effects of an acute alcohol and energy drink dose', Appetite, 76, pp. 60 - 65,
    Journal articles | 2014
    Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers R; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing A; Reiss P; van Sighem AI; Nelson M; Emery S; Montaner JSG; Lane HC; Larder BA; Reiss P; van Sighem A; Montaner J; Harrigan R; Rinke de Wit T; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Nelson M; Pozniak A; Mandalia S; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias M-J; Carr A; Norris R; Hesse K; Vlahakis E; Tempelman H; Barth R; Morrow C; Wood R; Ene L; Dragovic G; Cooper D; Torti C; Baxter J; Monno L; Torti C; Gatell J; Clotet B; Picchio G; deBethune M-P; Perez-Elias M-J, 2014, 'An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes', Journal of Antimicrobial Chemotherapy, 69, pp. 1104 - 1110,
    Journal articles | 2014
    Romero L; Nieuwenhuijse M; Carr A; Sedrakyan A, 2014, 'Review of clinical outcomes-based anchors of minimum clinically important differences in hip and knee registry-based reports and publications', Journal of Bone and Joint Surgery - American Volume, 96, pp. 98 - 103,
    Journal articles | 2014
    Tong WWY; Hillman RJ; Kelleher AD; Grulich AE; Carr A, 2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, 15, pp. 65 - 76,
    Journal articles | 2013
    Guy R; El-Hayek C; Fairley CK; Wand H; Carr A; McNulty A; Hoy J; Bourne C; McAllister J; Tee BK; Baker D; Roth N; Stoove M; Chen M, 2013, 'Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia', PLoS ONE, 8,
    Journal articles | 2013
    Guy R; Wand H; McManus H; Vonthanak S; Woolley I; Honda M; Read T; Sirisanthana T; Zhou J; Carr A, 2013, 'Antiretroviral treatment interruption and loss to follow-Up in Two HIV Cohorts in Australia and Asia: Implications for 'Test and Treat' Prevention Strategy', AIDS Patient Care and STDs, 27, pp. 681 - 691,
    Journal articles | 2013
    Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, 27, pp. 1245 - 1251,
    Journal articles | 2013
    Mcallister J; Beardsworth G; Lavie E; Macrae K; Carr A, 2013, 'Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting', HIV Medicine, 14, pp. 120 - 124,
    Journal articles | 2013
    Peacock A; Bruno R; Martin FH; Carr A, 2013, 'The Impact of Alcohol and Energy Drink Consumption on Intoxication and Risk-Taking Behavior', Alcoholism: Clinical and Experimental Research, 37, pp. 1234 - 1242,
    Journal articles | 2013
    Peacock A; Martin FH; Carr A, 2013, 'Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes', Appetite, 64, pp. 1 - 4,
    Journal articles | 2013
    Petoumenos K; Van Leeuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG, 2013, 'Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)', HIV Medicine, 14, pp. 77 - 84,
    Journal articles | 2013
    Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing AMJ; DeWolf F; Nelson M; Montaner JS; Lane HC; Larder BA; RDI study group , 2013, 'Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.', J Antimicrob Chemother, 68, pp. 1406 - 1414,
    Journal articles | 2013
    Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, 13, pp. 396 - 396,
    Journal articles | 2013
    Tong WWY; Jin F; McHugh LC; Maher T; Sinclair B; Grulich AE; Hillman RJ; Carr A, 2013, 'Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men', AIDS, 27, pp. 2233 - 2243,
    Journal articles | 2013
    Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M; Cooper D; Petoumenos K; Carr A; Bloch M; Han A, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, 13, pp. 471,
    Journal articles | 2012
    Bloch MT; Hoy JF; Cummingham N; Roth N; Bailey M; Pearce D; Watson J; Carr AD, 2012, 'Adherence to HIV treatment guidelines for comorbid disease assessment and inititation of antiretroviral therapy', Journal of Acquired Immune Deficiency Syndrome, 59, pp. 478 - 488,
    Journal articles | 2012
    Botes LP; Pett SL; Carr AD; Marriott D; Cooper DA; Matthews G; Carbone S; Kumaradevan N; Mchugh L; Hillman R, 2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, 10, pp. 9 - 17,
    Journal articles | 2012
    Carr A; Hoy J; Pozniak A, 2012, 'The ethics of switch/simplify in antiretroviral trials: Non-inferior or just inferior?', PLoS Medicine, 9,
    Journal articles | 2012
    Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377,
    Journal articles | 2012
    Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 4 - 4,
    Journal articles | 2012
    Koelsch KK, 2012, 'No significant effect of uridine or pravastatin treatment for HIV lip atrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomised trial.', HIV Medicine, 11, pp. 493 - 501
    Journal articles | 2012
    Lam UT; Yoganathan R; Carr A; Mammucari R; Foster NR, 2012, 'Encapsulation of superparamagnetic iron oxide nanoparticles by the supercritical antisolvent process', Australian Journal of Chemistry, 65, pp. 40 - 44,
    Journal articles | 2012
    Lee FJ; Carr A, 2012, 'Tolerability of HIV integrase inhibitors', Current Opinion in HIV and AIDS, 7, pp. 422 - 428,
    Journal articles | 2011
    Arenas-pinto A; Grant A; Bhaskarin K; Copas A; Carr AD; Worm SW; Martinez E; Reiss P; Dunn ; Weber R; Hoy JF; Weller IV, 2011, 'Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis', Antiviral Therapy, 16, pp. 219 - 226,
    Journal articles | 2011
    Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, 8, pp. 257 - 258,
    Journal articles | 2011
    Carr AD, 2011, 'Statins as Anti-inflammatory Therapy in HIV Disease?', Journal of Infectious Diseases, 203, pp. 751 - 752,
    Journal articles | 2011
    Carr AD, 2011, 'eGFR Slope and Tenofovir Nephrotoxicity', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 56, pp. 95 - 96
    Journal articles | 2011
    Carr AG; Mammucari R; Foster NR, 2011, 'A review of subcritical water as a solvent and its utilisation for the processing of hydrophobic organic compounds', Chemical Engineering Journal, 172, pp. 1 - 17,
    Journal articles | 2011
    Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, 13, pp. 240 - 250,
    Journal articles | 2011
    Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr A, 2011, 'Lower fat mass and lower bone formation predict greater bone loss with tenofovir in HIV-infected adults', ANTIVIRAL THERAPY, 16, pp. A6 - A7,
    Journal articles | 2011
    Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, 8, pp. 255 - 256,
    Journal articles | 2011
    Hoy J; Grund B; Roediger MP; Brar I; Colebunders R; De Castro N; Johnson M; Sharma A; Carr A, 2011, 'Plasma markers of bone loss and bone formation decrease with intermittent antiretroviral therapy and predict change in bone mineral density', ANTIVIRAL THERAPY, 16, pp. A5 - A6,
    Journal articles | 2011
    Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, 6, pp. Article number e26885,
    Journal articles | 2011
    McNulty A; Carr AD, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, 41, pp. 365 - 365,
    Journal articles | 2011
    Mcnulty A; Carr A, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, 41, pp. 365 - 365,
    Journal articles | 2011
    O''connor MB; O Connor C; Horgan M; Carr AD; Cooper DA, 2011, 'Sexual activity of HIV patients', Irish Journal of Medical Science, 180, pp. 777 - 779,
    Journal articles | 2011
    Wand HC; Carey DL; Calmy A; Law MG; Cooper DA; Emery S; Carr AD, 2011, 'Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes', Open Access Journal of Clinical Trials, 3, pp. 1 - 7,
    Journal articles | 2011
    Wright ST; Carr AD; Woolley I; Giles M; Hoy JF; Cooper DA; Law MG, 2011, 'CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts', Journal of acquired immune deficiency syndromes (1999), 58, pp. 72 - 79,
    Journal articles | 2010
    Amin J; Martin A; Bloch M; Carr A, 2010, 'Reply to Landman and Soonawala', Clinical Infectious Diseases, 50, pp. 1200 - 1201,
    Journal articles | 2010
    Bloch M; Hoy J; Cunningham N; Roth N; Andrianopoulos N; Rayner C; Carr A, 2010, 'Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia', Journal of the International AIDS Society, 13,
    Journal articles | 2010
    Calmy A; Fux CA; Delhumeau C; Carr A, 2010, 'Correspondence : Reply to Gazzola et al', Journal of Infectious Diseases, 202, pp. 331 - 332,
    Journal articles | 2010
    Carr A; Branch A; Mammucari R; Foster NR, 2010, 'The solubility and solubility modelling of budesonide in pure and modified subcritical water solutions', Journal of Supercritical Fluids, 55, pp. 37 - 42,
    Journal articles | 2010
    Carr A; Hoy J, 2010, 'Low bone mineral density with tenofovir: Does statistically significant mean clinically significant?', Clinical Infectious Diseases, 51, pp. 973 - 975,
    Journal articles | 2010
    Carr A; Mammucari R; Foster NR, 2010, 'Particle formation of budesonide from alcohol-modified subcritical water solutions', International Journal of Pharmaceutics, 405, pp. 169 - 180,
    Journal articles | 2010
    Carr A; Mammucari R; Foster NR, 2010, 'Solubility and Micronization of Griseofulvin in Subcritical Water', Industrial and Engineering Chemistry Research, 49, pp. 3403 - 3410,
    Journal articles | 2010
    Carr AG; Mammucari R; Foster NR, 2010, 'Solubility, solubility modeling, and precipitation of naproxen from subcritical water solutions', Industrial and Engineering Chemistry Research, 49, pp. 9385 - 9393,
    Journal articles | 2010
    Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, 24, pp. 2657 - 2663
    Journal articles | 2010
    Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, 11, pp. e0160673,
    Journal articles | 2010
    Samaras K; Richardson R; Carr AD, 2010, 'Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults', AIDS, 24, pp. 1727 - 1731,
    Journal articles | 2010
    Sinn K; Richardson R; Carr AD, 2010, 'Lower arterial stiffness and framingham score after switching abacavir to tenofovir in men at high cardiovascular risk', AIDS, 24, pp. 2403 - 2405
    Journal articles | 2010
    Wever K; Van Agtmael MA; Carr A, 2010, 'Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men', Journal of Acquired Immune Deficiency Syndromes, 55, pp. 78 - 81,
    Journal articles | 2010
    Yan C; Hanafi I; Kelleher AD; Carr AD; Amin J; Mcnally L; Cunningham PH, 2010, 'Lack of correlation between three commerical platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification', Journal of Clinical Virology, 49, pp. 249 - 253
    Journal articles | 2009
    Calmy A; Fux C; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr AD; Hesse , 2009, 'Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study', Journal of Infectious Diseases, 200, pp. 1746 - 1754,
    Journal articles | 2009
    Calmy A; Gayet-Ageron A; Montecucco F; Nguyen A; Mach F; Burger F; Ubolyam S; Carr A; Ruxungtham K; Hirschel B; Ananworanich J, 2009, 'HIV increases markers of cardiovascular risk: Results from a randomized, treatment interruption trial', AIDS, 23, pp. 929 - 939,
    Journal articles | 2009
    Calmy A; Hirschel B; Cooper DA; Carr AD, 2009, 'A new era of antiretroviral drug toxicity', Antiviral Therapy, 14, pp. 165 - 179
    Journal articles | 2009
    Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172
    Journal articles | 2009
    Carr AD; Amin J, 2009, 'Efficacy and tolerability of initial antiretroviral therapy: A systematic review', AIDS, 23, pp. 343 - 353
    Journal articles | 2009
    Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, 23, pp. 1519 - 1529
    Journal articles | 2009
    Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, 49, pp. 1591 - 1601
    Journal articles | 2009
    Mitsuyasu RT; Merigan T; Carr AD; Zack J; Winters M; Workman C; Bloch MT; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; Mcfarlane R; Smith DE; Garsia R; Ma DD; Law MG; Murray JM; Von Kalle C; Ely JA; Patino S; Knop A; Wong P; Todd A; Haughton M; Fuery C; Marcpherson J; Symonds G; Evans L; Pond SM; Cooper DA; Cooper D; Han A, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells', Nature Medicine, 15, pp. 285 - 292,
    Journal articles | 2009
    O'Connor MB; O'Connor C; Saunders JA; Sheehan C; Murphy E; Horgan M; Carr A; Cooper DA, 2009, 'HIV positive: Who do they tell?', International Journal of STD and AIDS, 20, pp. 517 - 518,
    Journal articles | 2009
    Samaras K; Gan SK; Peake PW; Carr AD; Campbell LV, 2009, 'Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection', Obesity, 17, pp. 53 - 59
    Journal articles | 2009
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461
    Journal articles | 2008
    Boyd MA; Truman M; Holes G; Anderson JA; Dwyer DE; Carr AD, 2008, 'A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study)', Antiviral Therapy, 13, pp. 449 - 453
    Journal articles | 2008
    Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110,
    Journal articles | 2008
    Carr AD; Grund B; Neuhaus J; El-Sadr W; Grandits G; Gibert C; Prineas R, 2008, 'Asymptomatic myocardial ischaemia in HIV-infected adults', AIDS, 22, pp. 257 - 267,
    Journal articles | 2008
    Carr AD; Ritzhaupt A; Zhang W; Zajdenverg R; Workman C; Gatell J; Cahn PE; Chaves R, 2008, 'Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults', AIDS, 22, pp. 2313 - 2321
    Journal articles | 2008
    Carr AD, 2008, 'Pathogenesis of cardiovascular disease in HIV infection', Current opinion in HIV & AIDS, 3, pp. 234 - 239
    Journal articles | 2008
    El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, 149, pp. 289 - W62
    Journal articles | 2008
    Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, 197, pp. 1133 - 1144,
    Journal articles | 2008
    Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, 197, pp. 1145 - 1155,
    Journal articles | 2008
    Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803
    Journal articles | 2008
    Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, pp. 2143 - 2153
    Journal articles | 2008
    Phillips AN; Carr AD; Neuhaus J; Visnegarwala F; Prineas R; Burman W; Williams IR; Drummond F; Duprez D; Belloso WH; Goebel F; Grund B; Hatzakis A; Vera J; Lundgren JD, 2008, 'Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial', Antiviral Therapy, 13, pp. 177 - 187
    Journal articles | 2007
    Arenas-Pinto A; Copas A; Weller I; Grant A; Dunn D; Bhaskaran K; Carr A; Reiss P; Edwards S; Worm SW; Overton T; Martinez E; Hoy J; Cahn P; Weber R, 2007, 'Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy', AIDS, 21, pp. 2455 - 2464,
    Journal articles | 2007
    Boyd MA; Truman M; Hales GP; Anderson JS; Dwyer DE; Carr AD, 2007, 'A randomized study to evaluate injection site reactions (ISR) using three different mechanisms for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge needle and a needle-free device', Antiviral Therapy, 12, pp. L57 - L57,
    Journal articles | 2007
    Calmy A; Hirschel B; Cooper DA; Carr AD, 2007, 'Clinical update: adverse effects of antiretroviral therapy', Lancet, 370, pp. 12 - 14
    Journal articles | 2007
    Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, 8, pp. 171 - 180
    Journal articles | 2007
    Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589
    Journal articles | 2007
    Carr A, 2007, 'Treatment strategies for HIV lipodystrophy', Current Opinion in HIV and AIDS, 2, pp. 332 - 338,
    Journal articles | 2007
    Carr AD; Zajdenverg R; Workman C; Gatell J; Cahn PE; Ritzhaupt A; Zhang W; Chaves R, 2007, 'Effects of tipranavir/r (500/200 or 500/100 mg BID) in comparison with lopinavir/r (400/100 ing BID) on changes in body composition and metabolic parameters in ARV-naive patients over 48 weeks', Antiviral Therapy, 12, pp. L8 - L9
    Journal articles | 2007
    Ellis KJ; Grund B; Visnegarwala F; Thackeray L; Miller CG; Chesson CE; El-Sadr W; Carr A, 2007, 'Visceral and subcutaneous adiposity measurements in adults: Influence of measurement site', Obesity, 15, pp. 1441 - 1447,
    Journal articles | 2007
    Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, 8, pp. 112 - 123,
    Journal articles | 2007
    May M; Sterne JA; Shipley M; Brunner E; d Agostino R; Whincup P; Ben-Shlomo Y; Carr AD; Ledergerber B; Lundgren JD; Phillips A; Massaro J; Eggerl M, 2007, 'A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men', International Journal of Epidemiology, 36, pp. 1309 - 1318
    Journal articles | 2007
    Prineas R; Roediger M; Carr AD; El-Sadr W; Esser S; Grandits G; Knysz B; Palfreeman A, 2007, 'Effect of alternate treatment protocols on the incidence of electrocardiographic abnormalities among HIV-infected adults in the SMART trial', Antiviral Therapy, 12, pp. L11 - L11
    Journal articles | 2007
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455,
    Journal articles | 2007
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119,
    Journal articles | 2007
    Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, 21, pp. 2445 - 2453
    Journal articles | 2006
    Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202
    Journal articles | 2006
    Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650
    Journal articles | 2006
    Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, 11, pp. L12 - L12,
    Journal articles | 2006
    Carr A; Ory D, 2006, 'Does HIV cause cardiovascular disease?', PLoS Medicine, 3, pp. 1986 - 1987,
    Journal articles | 2006
    Carr AD, 2006, 'Investigating new antiretroviral combinations', Journal of Infectious Diseases, 193, pp. 1742 - 1742
    Journal articles | 2006
    Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, 166, pp. 1632 - 1641,
    Journal articles | 2006
    Hamlyn E; McAllister J; Winston A; Sinclair B; Amin J; Carr AD; Cooper DA, 2006, 'Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?', Sexually Transmitted Infections, 82, pp. 21 - 23
    Journal articles | 2006
    Law MG; Puls R; Cheng A; Cooper DA; Carr AD, 2006, 'Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults', Antiviral Therapy, 11, pp. 179 - 186
    Journal articles | 2006
    Mallon PW; Miller JE; Kovacic JC; Kent-Hughes J; Norris RP; Samaras K; Feneley MP; Cooper DA; Carr AD, 2006, 'Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men - a randomized, placebo-controlled study', AIDS, 20, pp. 1003 - 1010,
    Journal articles | 2006
    Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85
    Journal articles | 2006
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24,
    Journal articles | 2006
    Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, 7, pp. 105 - 111
    Journal articles | 2005
    Behrens GMN; Grinspoon S; Carr A, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults [4] (multiple letters)', New England Journal of Medicine, 352, pp. 1721 - 1722,
    Journal articles | 2005
    Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, 19, pp. 1325 - 1327
    Journal articles | 2005
    El-Sadr W; Mullin C; Carr AD; Gibert C; Rappoport C; Visnegarwala F; Grunfeld C; Raghavan S, 2005, 'Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort', HIV Medicine, 6, pp. 114 - 121
    Journal articles | 2005
    Grinspoon S; Carr A, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults', New England Journal of Medicine, 352, pp. 48 - 62,
    Journal articles | 2005
    Grinspoon SK; Carr AD, 2005, 'Cardiovascular risk and body-fat abnormalities in HIV-infected adults - Reply', New England Journal of Medicine, 352, pp. 1722 - 1722
    Journal articles | 2005
    Grinspoon SK; Carr AD, 2005, 'Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults', New England Journal of Medicine, 352, pp. 48 - 62
    Journal articles | 2005
    Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, 10, pp. 135 - 143
    Journal articles | 2005
    Lim H; Sedwell R; Duarte NL; Cooper DA; Kelleher AD; Carr AD; Mallon PW, 2005, 'Nucleoside reverse transcriptase inhibitor effects on adipocyte mitochondrial DNA quantity and quality in vitro', Antiviral Therapy, 10, pp. L41 - L42
    Journal articles | 2005
    Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Ganning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray JM; Gerlach W; Sun L; Penny R; Symonds GP; Carr AD; Cooper DA, 2005, 'Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients', Journal of Gene Medicine, 7, pp. 552 - 564
    Journal articles | 2005
    Mallon PW; Miller JM; Kovacic JC; Kent-Hughes J; Norris RP; Samaras K; Feneley MP; Cooper DA; Carr AD, 2005, 'Changes in body composition and cardiovascular measures in hypercholesterolaemic HIV-infected men treated with pravastatin: a randomized, placebo-controlled study', Antiviral Therapy, 10, pp. L15 - L16,
    Journal articles | 2005
    Mallon PW; Sedwell R; Unemori P; Kelleher AD; Cooper DA; Carr AD, 2005, 'Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy', Antiviral Therapy, 10, pp. M101 - M108
    Journal articles | 2005
    Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, 191, pp. 1686 - 1696
    Journal articles | 2005
    Mallon PW; Wand HC; Law MG; Miller J; Cooper DA; Carr AD, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 38, pp. 156 - 162,
    Journal articles | 2005
    Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163
    Journal articles | 2005
    Sedwell R; Mallon PW; Duarte NL; Zaunders J; Kelleher AD; Cooper DA; Carr AD, 2005, 'Impaired mitochondrial function induced by NRTIs is only detectable in the monocyte (CD14(+)) subset of human PBMC', Antiviral Therapy, 10, pp. L44 - L45,
    Journal articles | 2005
    Shulman N; Moyle G; Carr A; Boyle B, 2005, '12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005; Boston, Massachusetts, USA', HIV Clinical Trials, 6, pp. 169 - 181,
    Journal articles | 2005
    Visnegarwala F; Raghavan S; Mullin C; Bartsch G; Wang J; Kotler DP; Gibert C; Shlay J; Grunfeld C; Carr AD; El-Sadr W, 2005, 'Sex differences in the associations of HIV disease characteristics and body composition in anti retroviral-naive persons', American Journal of Clinical Nutrition, 82, pp. 850 - 856
    Journal articles | 2005
    Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, 10, pp. L5 - L5,
    Journal articles | 2005
    Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, 56, pp. 380 - 387
    Journal articles | 2005
    Winston A; McAllister J; Amin J; Cooper DA; Carr AD, 2005, 'The use of a triple nucleoside-nucleotide-regimen for occupational HIV post-exposure prophylaxis', HIV Medicine, 6, pp. 191 - 197
    Journal articles | 2004
    Calmy A; Pascual F; Ford N; Kulwichit W; Carr A, 2004, 'First-line and second-line antiretroviral therapy [7] (multiple letters)', Lancet, 364, pp. 329 - 330
    Journal articles | 2004
    Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, 9, pp. L46 - L46,
    Journal articles | 2004
    Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 Lipoatrophy', The Lancet, 363, pp. 1829 - 1829,
    Journal articles | 2004
    Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 lipoatrophy - Reply', Lancet, 363, pp. 1829 - 1829,
    Journal articles | 2004
    Carr AD; Workman C; Carey DL; Rogers GJ; Martin A; Baker DA; Wand HC; Law MG; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438,
    Journal articles | 2004
    Carr AD, 2004, 'Antiretroviral therapy for previously untreated HIV-1-infected adults:2NN, or just one?', Lancet, 363, pp. 1248 - 1250
    Journal articles | 2004
    Carr AD, 2004, 'First-line and second-line antiretroviral therapy - Author`s reply', Lancet, 364, pp. 330 - 330
    Journal articles | 2004
    Cavalcanti RB; Raboud J; Kain KC; Walmsley S; Carr A; Wand H, 2004, 'Rosiglitazone for HIV-1 lipoatrophy [3] (multiple letters)', Lancet, 363, pp. 1828 - 1829,
    Journal articles | 2004
    Ellis K; Grund B; Visnegarwala F; Mullin C; Miller C; Chesson C; El-Sadr W; Carr AD, 2004, 'Abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) measurements in HIV+ adults: influences of measurement site', Antiviral Therapy, 9, pp. L34 - L35
    Journal articles | 2004
    Hoy JF; Gahan M; Carr AD; Smith DE; Lewin S; Wesselingh S; Cooper DA, 2004, 'Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir', Journal of Infectious Diseases, 190, pp. 688 - 692,
    Journal articles | 2004
    Law MG; Cheng AJ; Cooper DA; Carr AD, 2004, 'Objective evaluation of HIV lipodystrophy case definition in a randomized 96 week clinical trial', Antiviral Therapy, 9, pp. L8 - L9,
    Journal articles | 2004
    Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62,
    Journal articles | 2004
    Mallon PW; Sedwell R; Unemori P; Merlin K; McGinley C; Ammaranond P; Peperias M; Rafferty M; Williams KM; Samaras K; Morey AL; Chisholm DJ; Kelleher AD; Cooper DA; Carr AD, 2004, 'Nucleoside reverse transcriptase inhibitors (NRTI) decrease adipocyte and monocyte mitochondrial (mt) messenger RNA transcription in the absence of changes in mtDNA or cell morphology', Antiviral Therapy, 9, pp. L56 - L57,
    Journal articles | 2004
    Mallon PW; Sedwell R; Unemori P; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, 9, pp. L56 - L56,
    Journal articles | 2004
    Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, 9, pp. L11 - L11,
    Journal articles | 2004
    Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, 5, pp. 192 - 200,
    Journal articles | 2004
    Martin A; Smith DE; Carr AD; Ringland C; Amin J; Emery S; Hoy JF; Workman C; Doong N; Freund J; Cooper DA, 2004, 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study', AIDS, 18, pp. 1029 - 1036,
    Journal articles | 2004
    Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98
    Journal articles | 2004
    Vanhems P; Voirin N; Philippe P; Hirschel B; Brassard J; Carr AD; Cooper DA; Perrin L; Allard R, 2004, 'The incubation period of acute retroviral syndrome as a multistepprocess - A parametric survival analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 37, pp. 1529 - 1533
    Journal articles | 2003
    Amin J; Moore A; Carr A; French MA; Law M; Emery S; Cooper DA, 2003, 'Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2', HIV Research & Clinical Practice, 4, pp. 252 - 261,
    Journal articles | 2003
    Amin J; Moore A; Carr AD; French MA; Law MG; Emery S; Cooper DA, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, 4, pp. 252 - 261
    Journal articles | 2003
    Bisson G; Gross R; Miller V; Weller I; Walker A; Arlett P; Carr A; Evans S; Graham D; Justice A; Kreft-Jais C; Lundgren JD; Munk B; Murray J; Pirmohamed M; Pizzuti D; Szarfman A; Writing group , 2003, 'Monitoring of long-term toxicities of HIV treatments: an international perspective.', AIDS, 17, pp. 2407 - 2417,
    Journal articles | 2003
    Carr A, 2003, 'Cardiovascular risk factors in HIV-infected patients', Journal of Acquired Immune Deficiency Syndromes, 34,
    Journal articles | 2003
    Carr A, 2003, 'Lactic acidemia in infection with human immunodeficiency virus', Clinical Infectious Diseases, 36,
    Journal articles | 2003
    Carr AD; Emery S; Law MG; Puls R; Lundgren JD; Powderly W, 2003, 'An objective case definition of lipodystrophy in HIV-infected adults: a case-control study', Lancet, 361, pp. 726 - 735
    Journal articles | 2003
    Carr AD; Law MG, 2003, 'An objective lipodystrophy severity grading scale using the lipodystrophy case definition score', Journal of Acquired Immune Deficiency Syndrome, 33, pp. 571 - 576,
    Journal articles | 2003
    Carr AD, 2003, 'Cardiovascular risk in HIV infection', Journal of Acquir Immun Defic Syndrome, 34, pp. 73 - 78
    Journal articles | 2003
    Carr AD, 2003, 'Enfuvirtide, an HIV-1 fusion inhibitor', New England Journal of Medicine, 349, pp. 1770 - 1771
    Journal articles | 2003
    Carr AD, 2003, 'HIV Lipodystrophy: risk factors, pathogenesis, diagnosis and management', AIDS, 17, pp. 141 - 148
    Journal articles | 2003
    Carr AD, 2003, 'Lactic acidemia in HIV infection', Clinical Infectious Diseases, 36, pp. 96 - 100
    Journal articles | 2003
    Carr AD, 2003, 'Toxicity of antiretroviral therapy and implications for drug development', Nature Rev Drug Discov, 2, pp. 624 - 634
    Journal articles | 2003
    Clegg AO; Williamson P; Biti RA; Cooper DA; Emery S; Carr AD; Stewart GJ, 2003, 'Chemokine receptor genotype and response to interleukin-2 therapy in HIB-1-infected individuals', Clinical Immunology, 106, pp. 36 - 40
    Journal articles | 2003
    Cunningham PH; Marriott D; Harris C; Hancock S; Carr AD; Cooper DA; Harris C, 2003, 'False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand', Journal of Clinical Virology, 26, pp. 163 - 169
    Journal articles | 2003
    Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD; Bartsch G; Dabis F; Houyez F; Loeliger E; Tressler R; Weller I; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Meester R; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J; de Wolf F; van der Ven E; Zaheri S; Van Valkengoed I; Bronsveld W; Weigel H; Brinkman K; Frissen P; ten Veen J; Hillebrand M; van Dam P; Schieveld S; Mulder J; van Gorp E; Meenhorst P; van Eeden A; Danner S; Claessen F; Perenboom R; Eeftinck Schattenkerk JK; Godfried M; Lange J; Lowe S; van der Meer J; Nellen F; Pogany K; van der Poll T; Prins J; Ruys T; van der Valk M; Wit F; Richter C; van Leusen R; Vriesendorp R; Jeurissen F; Kauffmann R; Koger E; Bravenboer B; ten Napel C; Sprenger HG; Law G; ten Kate RW; Leemhuis M; Kroon F; Schippers E; Schrey G; van der Geest S; Verbon A; Koopmans P; Keuter M; Telgt D; van der Ven A; van der Ende M; Gyssens I; de Marie S; Juttmann J; van der Heul C; Schneider M; Borleffs J; Hoepelman I; Jaspers C; Matute A; Schurink C, 2003, 'Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group', New England Journal of Medicine, 349, pp. 1993 - 2003,
    Journal articles | 2003
    Ioannidis JP; Trikalinos TA; Law MG; Carr AD, 2003, 'HIV lipodystrophy case definition using artificial neural network modelling.', Antiviral Therapy, 8, pp. 435 - 441
    Journal articles | 2003
    Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249
    Journal articles | 2003
    Mallon PW; Cooper DA; Carr AD, 2003, 'Longterm treatment complications. I', AIDS, pp. 127 - 144
    Journal articles | 2003
    Mallon PW; Cooper DA; Carr AD, 2003, 'Metabolic complications of antiretroviral therapy', AIDS and Other Manifestations of HIV Infection, pp. 853 - 868
    Journal articles | 2003
    Mallon PW; Miller J; Cooper DA; Carr AD, 2003, 'Prospective evaluation of the effects of antiretroviral therapy on body composition and metabolic parameters in HIV-1-infected men starting therapy', AIDS, 17, pp. 979
    Journal articles | 2003
    Mallon PW; Wand HC; Law MG; Miller JM; Cooper DA; Carr AD, 2003, 'Strong association between buffalo hump and high serum insulin concentrations in HIV-infected individuals', Antiviral Therapy, 8, pp. L61 - L61,
    Journal articles | 2003
    Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301
    Journal articles | 2003
    Petoumenos K; Carr AD, 2003, 'The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV Observational database', Journal of Clinical Virology, 26, pp. 209 - 222
    Journal articles | 2003
    Puls R; Carr AD, 2003, 'Practical applications of the HIV lipodystrophy case definition', AIDS Reader, 13, pp. 480 - 481
    Journal articles | 2003
    Raghavan S; Mullin C; Bartsch G; Wang J; Kotler DP; Shlay J; Gibert C; Grunfeld C; Carr AD, 2003, 'Association between HIV disease characteristics with total and regional body composition levels in antiretroviral-naive men and women', Antiviral Therapy, 8, pp. L66 - L66
    Journal articles | 2003
    Smith DE; Hudson J; Martin A; Freund J; Griffiths MR; Kalnins S; Law M; Carr A; Cooper DA; Group and Investigators FTPD, 2003, 'Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy', HIV Research & Clinical Practice, 4, pp. 45 - 49,
    Journal articles | 2003
    Smith DE; Hudson J; Martin A; Freund J; Griffiths MR; Kalnins S; Law MG; Carr AD; Cooper DA, 2003, 'Centralised assessment of dual-energy x-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophy', HIV Clinical Trials, 4, pp. 45 - 49
    Journal articles | 2003
    Smith DE; Kaufmann GR; Kahn JO; Hecht FM; Grey PA; Zaunders J; Cunningham PH; Carr AD; Duncombe CJ; Quan D; Petersen A; Cooper DA, 2003, 'Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine and nelfinavir before complete HIV type 1 seroconversion', AIDS Research and Human Retroviruses, 19, pp. 189 - 199
    Journal articles | 2003
    Smith DG; Carr AD; Law MG; Martin A; Hoy JF; Hudson J; Cooper DA, 2003, 'Thymidine analogue withdrawal for patients on protease sparing therapy improves lipoatrophy but compromises antivrial control:the PIILR extension study', AIDS, 16, pp. 2489 - 2491,
    Journal articles | 2003
    Vanhems P; Voirin N; Hirschel B; Cooper DA; Vizzard J; Carr A; Perrin L, 2003, 'Incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS', Journal of Acquired Immune Deficiency Syndromes, 32, pp. 542 - 544,
    Journal articles | 2003
    Vanhems P; Voirin N; Hirschel B; Cooper DA; Vizzard J; Carr AD; Perrin L, 2003, 'Swiss HIV Cohort Study. Incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS', Journal of Acquir Immun Defic Syndrome, 32, pp. 542 - 544
    Journal articles | 2002
    Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, 3, pp. 28 - 36
    Journal articles | 2002
    Carr A; Cooper D; Darbyshire J; Dubé M; Peto T; Raghavan S; Reiss P; Walker S; Weller I; Zackin R, 2002, 'The evaluation of metabolic function and fat redistribution in clinical trials', HIV Medicine, 3, pp. 65 - 72,
    Journal articles | 2002
    Carr A; Cooper DA; Molina JM; Tourneur M, 2002, 'Fumagillin for intestinal microsporidiosis [4] (multiple letters)', New England Journal of Medicine, 347, pp. 1381,
    Journal articles | 2002
    Carr A; Cooper DA, 2002, 'Fumagillin for intestinal microsporidiosis', NEW ENGLAND JOURNAL OF MEDICINE, 347, pp. 1381 - 1381,
    Journal articles | 2002
    Carr AD; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy', Journal of the American Medical Association, 288, pp. 1716,
    Journal articles | 2002
    Carr AD; Cooper DA, 2002, 'Fumagillin for microsporidiosis', New England Journal of Medicine, 347, pp. 1381 - 1381
    Journal articles | 2002
    Carr AD; Cooper DA, 2002, 'Fumagillin treatment of intestinal microsporidiosis', New England Journal of Medicine, 347, pp. 1381
    Journal articles | 2002
    Carr AD; Law MG; Baker D; Petoumenos K; Smith D; Anderson JA; Roth N; Mallal SS, 2002, 'Rates of combination antiretroviral treatment change in Australia', HIV Medicine, 3, pp. 28 - 36
    Journal articles | 2002
    Carr AD; Workman C; Smith DE; Hoy JF; Doong N; Amin J; Law MG; Cooper DA, 2002, 'For the MITOX investigators: Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial', Journal of the American Medical Association, 288, pp. 207 - 215
    Journal articles | 2002
    Carr AD; Workman C; Smith DE; Hoy JF; Hudson J; Doong N; Martin A; Amin J; Freund J; Law MG; Cooper DA, 2002, 'Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy', JAMA - Journal of the American Medical Association, 288, pp. 207 - 215
    Journal articles | 2002
    Carr AD, 2002, 'Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy', The Lancet, 360, pp. 81 - 85
    Journal articles | 2002
    Carr AD, 2002, 'Liver dysfunction associated with antiretroviral therapy', HIVINSITE, pp. 1
    Journal articles | 2002
    Carr AD, 2002, 'Virologic outcomes of complex drug regimens for human immunodeficiency virus', Journal of the American Medical Association, 288, pp. 2405 - 2406
    Journal articles | 2002
    French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D; investigators* OBOO2, 2002, 'Randomized, open-Label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: The OzCombo 2 study', HIV Research & Clinical Practice, 3, pp. 177 - 185,
    Journal articles | 2002
    French MA; Amin J; Roth N; Law MG; Emery S; Drummond F, 2002, 'Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: The OzCombo 2 Study', HIV Clinical Trials, 3, pp. 177 - 185
    Journal articles | 2002
    Gan SK; Samaras K; Thompson CH; Kraegen EW; Carr AD; Cooper DA; Chisholm DJ, 2002, 'Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy', Diabetes, 51, pp. 3163 - 3169,
    Journal articles | 2002
    Mallon PW; Carr AD; Cooper DA, 2002, 'HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways', Current Diabetes Reports, 2, pp. 116 - 124
    Journal articles | 2002
    Mikhailof N; Carr A; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy [1] (multiple letters)', Journal of the American Medical Association, 288, pp. 1716,
    Journal articles | 2002
    Miller J; Brown DA; Amin J; Kent-Hughes J; Law MG; Cooper DA; Carr AD, 2002, 'A randomised, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia', AIDS, 16, pp. 2195 - 2200
    Journal articles | 2002
    Moyle G; Carr A, 2002, 'HIV-associated lipodystropy, metabolic complications, and antiretroviral toxicities', HIV Clinical Trials, 3, pp. 89 - 98
    Journal articles | 2002
    Schambelan M; Benson CA; Carr AD; Currier JS; Dube MP; Gerber JG; Grinspoon SK; Grunfeld C; Kotler DP; Mulligan K; Powderly W; Saag MS, 2002, 'Management of the metabolic complications assoicated with antiretroviral therapy for HIV-1 infection:recommedations of an International AIDS society-USA', Journal of Acquir Immun Defic Syndrome, 31, pp. 257 - 275
    Journal articles | 2002
    Smith DE; Carr AD; Law MG; Hudson J; Hoy JF; Cooper DA, 2002, 'Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study', AIDS, 16, pp. 2489 - 2491
    Journal articles | 2002
    Vandems V; Caillat-Vallet E; Hirschel B; Routy J; Carr AD; Vizzard J; Cooper DA; Perrin L, 2002, 'The CD4 cell count 3 months after severe retroviral syndrome is associated with the presence of AIDS in the source individual', AIDS, 16, pp. 2234 - 2236
    Journal articles | 2002
    Vanhems P; Caillat-Vallet E; Hirschel B; Routy J; Carr AD; Vizzard J; Cooper DA; Perrin L, 2002, 'The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual', AIDS, 16, pp. 2234 - 2236
    Journal articles | 2002
    Vanhems P; Routy J; Hirschel B; Baratin D; Vora S; Carr AD; Maenza J; Trepo C; Touraine JL; Gillibert R; Collier AC; Cooper DA; Vizzard J; Sekaly R; fabry J; Perrin L, 2002, 'Clinical features of the acute retroviral syndrome differ by route of infection but not by gender and age', Journal of Acquir Immun Defic Syndrome, 31, pp. 318 - 321
    Journal articles | 2002
    Wilkinson J; Zaunders J; Carr AD; Guillemin GJ; Cooper DA, 2002, 'Characterization of the phenotypic and lymphokine profile associated with strong CD8+ anti-HIV-1 suppressor activity (CASA', Clinical and Experimental Immunology, 127, pp. 145 - 150,
    Journal articles | 2001
    Blanco F; Carr A, 2001, 'Lipodystrophy syndrome: Diagnostic, clinic and therapeutic aspects', AIDS Reviews, 3, pp. 98 - 105
    Journal articles | 2001
    Carr A; Morey A; Mallon P; Williams D; Thorburn DR, 2001, 'Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia', Lancet, 357, pp. 1412 - 1414,
    Journal articles | 2001
    Carr A, 2001, 'Osteopenia in HIV infection.', AIDS clinical care, 13
    Journal articles | 2001
    Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 162 - 168
    Journal articles | 2001
    Carr AD; Hudson J; Chuah J; Law MG; Mallal SA; Hoy JF; Doong N; French MA; Smith DE; Cooper DA, 2001, 'HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study', AIDS, 15, pp. 1811 - 1822
    Journal articles | 2001
    Carr AD; Miller J; Eisman JA; Cooper DA, 2001, 'Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy', AIDS, 15, pp. 703 - 709
    Journal articles | 2001
    Gan SK; Samaras K; Carr AD; Chisholm DJ, 2001, 'Anti-retroviral therapy, insulin resistance and lipodystrophy', Diabetes Obesity and Metabolism, pp. 67 - 71
    Journal articles | 2001
    Mallon PW; Cooper DA; Carr AD, 2001, 'HIV¿associated lipodystrophy.', HIV Medicine, 2, pp. 166 - 173
    Journal articles | 2001
    Mooser V; Carr A, 2001, 'Antiretroviral therapy-associated hyperlipidaemia in HIV disease', Current Opinion in Lipidology, 12, pp. 313 - 319,
    Journal articles | 2001
    Powderly WG; Carr A, 2001, 'AIDS 2001. Clinical treatment. Overview.', AIDS, 15 Suppl 5
    Journal articles | 2001
    Powderly WG; Carr A, 2001, 'Clinical treatment', AIDS, 15,
    Journal articles | 2001
    Sabin CA; Olmscheid B; Moyle G; Carr A; Boyle B; Cohen C; Cooper D; Deeks S; Gulick T; Saag M, 2001, 'Selected topics from the 8th Conference on Retroviruses and Opportunistic Infections. February 4-8, 2001. Chicago, Illinois.', HIV Clin Trials, 2, pp. 366 - 386,
    Journal articles | 2001
    Zaunders J; Kaufmann GR; Cunningham PH; Smith DE; Grey PA; Suzuki K; Carr AD; Goh L; Cooper DA, 2001, 'Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.', Journal of Infectious Diseases, 183, pp. 736 - 743
    Journal articles | 2000
    Carr A; Morey A; Cooper DA; Thorburn DR, 2000, 'Chronic liver failure and persistent mitochondrial dysfunction 2 years after nucleoside reverse transcriptase inhibitor (NRTI)-induced acute hepatitis and lactic acidemia', AIDS, 14, pp. S64 - S64,
    Journal articles | 2000
    Carr A; Yarchoan R, 2000, 'AIDS 2000. Clinical treatment: overview.', AIDS, 14 Suppl 3
    Journal articles | 2000
    Carr A, 2000, 'HIV protease inhibitor-related lipodystrophy syndrome', Clinical Infectious Diseases, 30,
    Journal articles | 2000
    Carr A, 2000, 'Lipodystrophy syndrome: Developing a case definition', AIDS, 14, pp. S13 - S13,
    Journal articles | 2000
    Carr AD; Chuah J; Hudson J; French MA; Hoy JF; Law MG; Sayer D; Emery S; Cooper DA; On BOTC, 2000, 'A randomised, open-label comparison of three highly active antiretroviral therapy regimes including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study', AIDS, 14, pp. 1171 - 1180
    Journal articles | 2000
    Carr AD; Cooper DA, 2000, 'Adverse effects of antiretroviral therapy', Lancet, pp. 1423 - 1430
    Journal articles | 2000
    Carr AD; Mills J; Law MG; Cooper DA, 2000, 'A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome', AIDS, 14, pp. 25 - 32
    Journal articles | 2000
    Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551
    Journal articles | 2000
    Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, 14, pp. 2406 - 2407
    Journal articles | 2000
    Rhodes DI; Ashton LJ; Solomon A; Carr AD; Cooper DA; Kaldor JM; Deacon N; For TAL-T, 2000, 'Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression', Journal of Virology, pp. 10581 - 10588
    Journal articles | 2000
    Sobanski MA; Barnes RA; Gray SJ; Carr AD; Kaczmarski EB; O'Rourke A; Murphy K; Cafferkey M; Ellis RW; Pidcock K; Hawtin P; Coakley WT, 2000, 'Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease', EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 19, pp. 260 - 266,
    Journal articles | 1999
    Baker R; Kotler D; Carr A; Torres RA, 1999, 'Altered body shape in HIV disease: A side effect of therapy?', AIDS Patient Care and STDs, 13, pp. 395 - 402,
    Journal articles | 1999
    Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DD; Penny R, 1999, 'The use of human immunodeficiency virus postexposure prophylaxis following successful artificial insemination', American Journal of Obstetrics and Gynecology, 181, pp. 760 - 761
    Journal articles | 1999
    Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DE, 1999, 'The use of human immunodeficiency virus post exposure prophylaxis after success-ful artificial insemination.', American Journal of Obstetrics and Gynecology, 181, pp. 760 - 761,
    Journal articles | 1999
    Carr AD; Samaras K; Thorisdottir A; Kaufmann GR; Chisholm DJ; Cooper DA, 1999, 'Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitis: a cohort study', The Lancet, pp. 2093 - 2099
    Journal articles | 1999
    Carr AD, 1999, 'HIV nucleoside analogues: new adverse effects on mitochondria', Lancet, pp. 1046 - 1047
    Journal articles | 1999
    Carr AD, 1999, 'Protease inhibitor-induced lipodystrophy', AIDS Reviews, 1, pp. 29 - 36
    Journal articles | 1999
    Cooper DA; Penny R; Symonds G; Carr AD; Gerlach W; Sun L; Ely JA, 1999, 'A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins', Human Gene Therapy, 10, pp. 1401 - 1421
    Journal articles | 1999
    Freund J; Carr A; Samaras K; Law M; Chisholm DJ; Cooper DA; Griffiths MR; Majerovic Y; Noakes KA, 1999, 'Peripheral lipodystrophy measured by DEXA in patients receiving HIV protease inhibitors', Nuclear Medicine Communications, 20, pp. 390 - 390,
    Journal articles | 1999
    Freund J; Griffiths MR; Majerovic Y; Noakes KA; Carr A; Cooper D, 1999, 'Skeletal display versus skeletal and soft tissue display analysis of whole-body composition', Nuclear Medicine Communications, 20, pp. 380 - 380,
    Journal articles | 1999
    Kaufmann GR; Cunningham PH; Zaunders J; Law MG; Vizzard J; Carr AD; Cooper DA, 1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 437 - 444
    Journal articles | 1999
    Vanhems P; Dassa C; Lambert J; Cooper DA; Perrin L; Vizzard J; Hirschel B; Kinloch-De Loes S; Carr AD; Allard R, 1999, 'Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 99 - 106
    Journal articles | 1999
    Wilkinson JG; Zaunders J; Carr AD; Cooper DA, 1999, 'CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia', Journal of Infectious Diseases, 180, pp. 68 - 75,
    Journal articles | 1999
    Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, 180, pp. 320 - 329
    Journal articles | 1998
    Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, 14, pp. 117 - 121
    Journal articles | 1998
    Carr A; Cooper DA, 1998, 'HIV and AIDS - Gap between biology and reality in AIDS', LANCET, 352, pp. 16 - 16,
    Journal articles | 1998
    Carr A; Cooper DA, 1998, 'Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.', The New England journal of medicine, 339, pp. 1296
    Journal articles | 1998
    Carr AD; Cooper DA, 1998, 'Gap between biology and reality in AIDS', Lancet, pp. 16 - 16
    Journal articles | 1998
    Carr AD; Cooper DA, 1998, 'Lipodystrophy associated with an HIV-protease inhibitor', New England Journal of Medicine, pp. 1296 - 1296
    Journal articles | 1998
    Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999,
    Journal articles | 1998
    Carr AD; Marriott D; Field AS; Vasak E; Cooper DA, 1998, 'Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy', Lancet, pp. 256 - 261
    Journal articles | 1998
    Carr AD; Samaras K; Burton S; Law MG; Freund J; Chisholm DJ; Cooper DA, 1998, 'A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors', AIDS, 12, pp. F51 - F58
    Journal articles | 1998
    Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Abnormal fat distribution and use of protease inhibitors', Lancet, pp. 1736 - 1736
    Journal articles | 1998
    Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance', Lancet, pp. 1881 - 1883
    Journal articles | 1998
    Collins S; Carr A; O'Keefe D, 1998, 'Evaluation of the effectiveness of a chronic pain management programme', Irish Journal of Psychology, 19, pp. 283 - 294,
    Journal articles | 1998
    Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, 178, pp. 1812 - 1815,
    Journal articles | 1998
    Kaufmann GR; Duncombe CJ; Cunningham PH; Beveridge A; Carr AD; Sayer D; French MA; Cooper DA, 1998, 'Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals', AIDS, 12, pp. 1625 - 1630,
    Journal articles | 1998
    Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, 113, pp. 85 - 91
    Journal articles | 1998
    McAlinden MG; Magowan J; Wilson DJ; Insley G; Ferris P; Prendergast PJ; Rice J; Blayney AW; Dalstra M; Walsh M; McGloughlin T; Grace P; Colgan D; Bray D; McCormack BAO; Reilly R; Tancred D; Carr AJ; Leyland NS; Meenan J; Boyd A; Akay M; O'Dwyer B; Dunne NJ; Ryan K; Orr JF; Stungo B; Brennan EG; O'Hare NJ; Walsh MJ; Jordan MF; Rasheed AM; Kelly C; Kay E; Bouchier-Hayes DJ; Leahy A; Maher SA; O'Reilly D; Foley J; Gillan MA; Cole JS; Raghunathan S; O'Reilly MJG; Kenny T; Hourigan TF; Lyons GM; Cox SL; Kernohan WG; Fitzpatrick C; Dempsey GJ; Millar I; Kelly S; Charlwood AP; O'Brien S; Beverland DE; Kavanagh A; Neligan MF; McKenna J; Laracy P; Moran D; O'Beirne J; Nixon JR; Kenny P; Maher SA; Murphy LA; O'Rourke SK; O'Donoghue D; Gilchrist MD; Caulfield B; O'Brien B; Simms C; Lyons CG; Brady CL; Badran S; Clifford PM; Burden DJ; Taylor D; Hill R; Griffin S; De Barra E; Brook I; Reytil P; Blades M; O'Reilly JP; Masterson BF; Macauley D; Toner M; Walker J; Gillan J; Meenan J; Murphy H; McNamara P; Jones E; Kelly P; Rajah L, 1998, 'Royal academy of medicine in Ireland section of bioengineering - Proceedings of meeting held in dundalk, co. louth, in february 1998.', Irish Journal of Medical Science, 167, pp. 256 - 276,
    Journal articles | 1998
    Ryan BM; McKiernan S; Keeling PWN; Byrne PJ; Quill R; McCallion K; Mitchell RMS; Watson RGP; Collins JSA; Gardiner KR; Winter DC; O'Sullivan GC; Taylor CT; Fanning NF; Redmond HP; O'Donoghue DP; Baird AW; Harvey BJ; Brannigan AE; O'Connell PR; Regan MC; Fitzpatrick JM; Watson RWG; Lemass H; Ryan E; MacMathuna P; Crowe J; O'Keane JC; Goh J; Baird A; Maher L; Godson C; Brady HR; Petasis NA; Fokin VV; Barry MK; Grant DC; Sheahan K; O'Donoghue DP; Hyland JMP; Sheehan KM; Fitzgerald DJ; Murray FE; Heaney A; Collins JSA; Bamford KB; McFarland RJ; Tham TCK; McNamara D; Franelli S; Whelan H; Hamilton H; Beattie S; O'Morain C; Brennan EG; O'Hare N; McDermott R; Byrne PJ; McDougall NI; Collins JSA; Gieeson CM; Russell SEH; Sloan JM; Morrisey D; Murphy L; Kiely B; Fitzgerald G; Daly C; O'Sullivan G; Shanahan F; Collins JK; Marteau P; Johnston SD; Coates C; Feighery C; O'Keeffe J; Whelan A; Lynch S; Weir DG; Abuzakouk M; Barnes L; O'Gorman N; McKenna M; Freaney R; Young M; Gaines S; Brady D; Drudy D; O'Farrelly C; Gilleece A; Fenelon L; McPartlin J, 1998, 'Irish society of gastroenterology - Proceedings of meeting held Friday 12th and Saturday 13th June, 1998', Irish Journal of Medical Science, 167, pp. 2 - 22,
    Journal articles | 1998
    Vanhems P; Lambert J; Cooper DA; Perrin L; Carr AD; Hirscher B; Vizzard J; Kinloch-De Loes S; Allard R, 1998, 'Severity and prognosis of acute human immunodeficiency virus type 1 illness. A dose-response relationship', Clinical Infectious Diseases, pp. 323 - 329
    Journal articles | 1998
    Wang LL; Witherington C; King AD; Gerlach W; Carr AD; Penny R; Cooper DA; Symonds G; Sun L, 1998, 'Preclinical characterization of an anti-tat ribozyme for therapeutic application', Human Gene Therapy, pp. 1283 - 1291
    Journal articles | 1998
    Wurtz R; Carr A; Samaras K; Chisholm DJ; Cooper DA; Ho TTY; Chan KCW; Wong KH; Lee SS, 1998, 'Abnormal fat distribution and use of protease inhibitors (multiple letters) [7]', Lancet, 351, pp. 1735 - 1736,
    Journal articles | 1997
    Carr A, 1997, 'Role of desensitisation for drug hypersensitivity in patients with HIV infection', Drug Safety, 17, pp. 119 - 126,
    Journal articles | 1997
    Carr AD; Brown DM; Cooper DA, 1997, 'Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor', AIDS, 11, pp. 1657 - 1658
    Journal articles | 1997
    Carr AD; Cooper DA, 1997, 'CD8 T-cell response to antiretroviral therapy', Journal of acquired immune deficiency syndrome and human retrovirology, 15, pp. 176 - 177
    Journal articles | 1997
    Carr AD; Cooper DA, 1997, 'Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy', Lancet, pp. 589 - 589
    Journal articles | 1997
    Carr AD; Cooper DA, 1997, 'Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor', Lancet, pp. 995 - 996
    Journal articles | 1997
    De Jong MD; Vella S; Carr AD; Boucher CA; Imrie A; French MA; Hoy JF; Sorice S; Pauluzzi S; Chiodo F; Weverling GJ; Van Der Ende ME; Frissen PJ; Weigel HM; Kauffmann RH; Lange JM; Yoon R; Moroni M; Hoenderos E; Leitz G; Cooper DA; Hall D; Reiss P, 1997, 'High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication', Journal of Infectious Diseases, 175, pp. 966 - 970
    Journal articles | 1997
    Imrie A; Beveridge A; Genn W; Vizzard J; Cooper DA; Catchpole BR; Baker D; Bloch M; Byrne J; Carr AD; Doong N; Duncombe CJ; Finlayson R; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1997, 'Transmission of human immunodeficiency virus type-1 resistant to nevirapine and zidovudine', Journal of Infectious Diseases, 175, pp. 1502 - 1506,
    Journal articles | 1997
    Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, 13, pp. 29 - 32
    Journal articles | 1997
    Mitchell SM; Youle MS; Membrey WL; Jones CD; Uthayakumar S; Birthistle K; Dalton R; Hay PE; Stricker RB; Goldberg B; Carr A; Cooper DA; Stein DS; Jacobson MA, 1997, 'Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy (multiple letters) [10]', Lancet, 350, pp. 588 - 590,
    Journal articles | 1997
    Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838
    Journal articles | 1997
    Stricker RB; Goldberg B; Carr A; Cooper DA, 1997, 'CD8 T-cell response to antiretroviral therapy [1] (multiple letters)', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, pp. 176 - 177,
    Journal articles | 1997
    Vanhems P; Allard R; Cooper DA; Perrin L; Vizzard J; Hirschel B; Kinloch-De Loes S; Carr AD; Lambert J, 1997, 'Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?', Clinical Infectious Diseases, pp. 965 - 970
    Journal articles | 1996
    Carr A; Boyle MJ, 1996, 'Managing HIV. Part 2: Phases of disease. 2.1 Primary HIV infection.', Med J Aust, 164, pp. 105 - 106,
    Journal articles | 1996
    Carr A; Boyle MJ, 1996, 'Managing HIV: 2.1 Primary HIV infection', Medical Journal of Australia, 164, pp. 105 - 106,
    Journal articles | 1996
    Carr A; Boyle MJ, 1996, 'Primary HIV infection', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 105 - 106,
    Journal articles | 1996
    Carr A; Garsia R, 1996, 'How HIV leads to hypersensitivity reactions', Medical Journal of Australia, 164, pp. 227 - 229,
    Journal articles | 1996
    Carr A; Garsia R, 1996, 'Managing HIV. Part 3: Mechanisms of disease. 3.5 How HIV leads to hypersensitivity reactions.', Med J Aust, 164, pp. 227 - 229,
    Journal articles | 1996
    Carr A; Roseingrave P; Fitzgerald MX, 1996, 'Factors associated with stress responses in staff caring for patients with cystic fibrosis', Irish Journal of Psychology, 17, pp. 241 - 250,
    Journal articles | 1996
    Carr AD; Cooper DA, 1996, 'Current clinical experience with nevirapine for HIV infection', Advances in Experimental Medicine and Biology, pp. 299 - 304
    Journal articles | 1996
    Carr AD; Cooper DA, 1996, 'HIV protease inhibitors', AIDS, 10, pp. 151 - 157
    Journal articles | 1996
    Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, 13, pp. 320 - 326
    Journal articles | 1996
    Carr AD; Vella S; Dejong MD; Sorice F; Imrie A; Boucher CA; Cooper DA, 1996, 'A controller trial of nevirapine plus zidovudine versis zidovudine aklone in p24 antigenaemic HIV infected patients', AIDS, 10, pp. 635 - 641
    Journal articles | 1996
    Cooper DA; Merigan TC, 1996, 'Clinical treatment.', AIDS (London, England), 10 Suppl A,
    Journal articles | 1996
    Coyle P; Carr AD; Depczynski BB; Chisholm DJ, 1996, 'Diabetes mellitus associated with pentamidine use in HIV-infected patients.', The Medical journal of Australia, 165, pp. 587 - 588,
    Journal articles | 1996
    Imrie A; Carr A; Duncombe C; Finlayson R; Vizzard J; Law M; Kaldor J; Penny R; Cooper DA, 1996, 'Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.', J Infect Dis, 174, pp. 195 - 198,
    Journal articles | 1996
    Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, 173, pp. 321 - 329
    Journal articles | 1996
    Zhu T; Wang N; Carr AD; Nam DS; Moor-Jankowski R; Cooper DA; Ho DD, 1996, 'Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions:evidence for viral compartmentalisation and selection during sexual transmission', Journal of Virology, pp. 3098 - 3107
    Journal articles | 1995
    Carr A; Cooper DA, 1995, 'Pathogenesis and management of HIV-associated drug hypersensitivity.', AIDS clinical review, pp. 65 - 97
    Journal articles | 1995
    Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'Safety, pharmacokinetics, and antiviral activity of ritonavir, an inhibitor of HIV-1 protease', JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 10, pp. 75 - 75,
    Journal articles | 1995
    Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Garcia de Lomas J; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease', New England Journal of Medicine, 333, pp. 1528 - 1534,
    Journal articles | 1995
    Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', The Medical journal of Australia, 163, pp. 508 - 509,
    Journal articles | 1995
    Kinloch-De Loes S; Hirschel B; Hoen B; Cooper DA; Tindall B; Carr AD; Saurat JH; Clumeck N; Lazzarin A; Mathiesen L; Raffi F; Antunes F; Von Overbeck J; Luthy R; Glauser M; Hawkins D; Baumberger C; Yerly S; Perneger TV; Perrin L, 1995, 'A controlled trial of zidovudine in primary human immunodeficiency virus infection', New England Journal of Medicine, pp. 408 - 413
    Journal articles | 1995
    ZHU TF; WANG N; NAM DS; CAO YZ; CARR A; COOPER D; HO DD, 1995, 'PREFERENTIAL TRANSMISSION OF CELL-ASSOCIATED VIRUS AND EVIDENCE FOR SELECTION OF HIV-1 IN THE NEW HOST FOLLOWING SEXUAL CONTACT', JOURNAL OF CELLULAR BIOCHEMISTRY, pp. 230 - 230,
    Journal articles | 1995
    Zaunders J; Carr AD; Mcnally L; Penny R; Cooper DA, 1995, 'Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes', AIDS, pp. 561 - 566
    Journal articles | 1995
    Zhu T; Wang N; Carr A; Wolinsky S; Ho DD, 1995, 'Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor', Journal of Virology, 69, pp. 1324 - 1327,
    Journal articles | 1994
    Carr A; Cooper DA, 1994, 'In HIVâ€infected individuals who desire combination antiviral therapy, zidovudine plus zalcitabine is preferred to zidovudine plus didanosine', Reviews in Medical Virology, 4, pp. 5 - 8,
    Journal articles | 1994
    Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA, 1994, 'Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients', AIDS, 8, pp. 333 - 337,
    Journal articles | 1994
    Carr A; Vasak E; Munro V; Penny R; Cooper DA, 1994, 'Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection', Clinical and Experimental Immunology, 97, pp. 260 - 265,
    Journal articles | 1993
    Carr A; Loewenthal M; Cooper DA, 1993, 'Update on reverse transcriptase inhibitors in HIV disease', Israel Journal of Medical Sciences, 29, pp. 26 - 30
    Journal articles | 1993
    Carr A; Penny R; Cooper DA, 1993, 'Allergy and desensitization to zidovudine in patients with acquired immunodeficency syndrome (AIDS)', The Journal of Allergy and Clinical Immunology, 91, pp. 683 - 685,
    Journal articles | 1993
    Carr A; Penny R; Cooper DA, 1993, 'Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients', AIDS, 7, pp. 65 - 71
    Journal articles | 1993
    Carr A; Penny R; Cooper DA, 1993, 'Prophylaxis of opportunistic infections in patients with HIV infection', Journal of Acquired Immune Deficiency Syndromes, 6, pp. S56 - S60
    Journal articles | 1993
    Carr A; Swanson C; Penny R; Cooper DA, 1993, 'Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS', Journal of Infectious Diseases, 167, pp. 180 - 185,
    Journal articles | 1993
    Carr A; Tindall B; Penny R; Cooper DA, 1993, 'In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV', Clinical and Experimental Immunology, 94, pp. 21 - 25,
    Journal articles | 1993
    Carr A; Tindall B; Penny R; Cooper DA, 1993, 'Patterns of multiple-drug hypersensitivities in HIV-infected patients [4]', AIDS, 7, pp. 1532 - 1533,
    Journal articles | 1993
    Caumes E; Lheriteau F; Gentilini M; Carr A; Tindall B; Cooper DA, 1993, 'Cotrimoxazole prophylaxis for toxoplasmosis [3]', Annals of Internal Medicine, 118, pp. 395,
    Journal articles | 1993
    Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, 7, pp. 127 - 128,
    Journal articles | 1993
    Tindall B; Elford J; Sharkey T; Carr A; Kaldor J; Cooper DA, 1993, 'CD4+ lymphocytopenia in HIV-seronegative homosexual men [4]', AIDS, 7, pp. 1272 - 1273
    Journal articles | 1993
    Tindall B; Forde S; Carr A; Barker S; Cooper DA, 1993, 'Attitudes to euthanasia and assisted suicide in a group of homosexual men with advanced HIV disease', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 1069 - 1070
    Journal articles | 1993
    Virus I; Masur H; Feinberg J; Bozzette SA; De Gruttola V; Edlin B; Eisinger R; El-Sadr W; Ellenberg S; Feigal D; Frame P; Goldberger M; Hafner R; Hardy WD; Harrington M; Hughes W; Kerkering T; Kovacs J; Leoung G; Montaner J; Muñoz A; Phair J; Sattler F; Spector S; Allen JR; Carr A; Chaisson R; Freedberg K; McKay J; Polis M, 1993, 'Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 46 - 55
    Journal articles | 1992
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, 117, pp. 106 - 111,
    Journal articles | 1992
    Carr A; Tindall B; Penny R; Cooper DA, 1992, 'Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS', AIDS, 6, pp. 165 - 171
    Journal articles | 1991
    Carr A; Cooper DA; Penny R, 1991, 'Allergic manifestations of human immunodeficiency virus (HIV) infection', Journal of Clinical Immunology, 11, pp. 55 - 64,
    Journal articles | 1990
    Carr A, 1990, 'Drug hypersensitivity', Medical Journal of Australia, 153, pp. 631,
  • Preprints | 2024
    Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2024, Self-reactive B cells traverse a perfect storm of somatic mutagenesis to cause a virus-induced autoimmune disease,
    Preprints | 2020
    Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried K; Lintzeris N, 2020, Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study,
    Conference Abstracts | 2019
    Calon M; Menon K; Juge L; Carr A; Henry R; Rae C; Brew B; Cysique L, 2019, 'Cardiovascular Disease Risk Factors and HIV Disease Markers Increase Dementia Risk and Alter White Matter Microstructure in Virally Suppressed HIV Infected Men', in JOURNAL OF NEUROVIROLOGY, SPRINGER, GA, Atlanta, Vol. 25, pp. S6 - S7, presented at 16th International Symposium on NeuroVirology, GA, Atlanta, 12 November 2019 - 16 November 2019,
    Conference Posters | 2019
    Carr M; Martin SJ; Foster R; Finlayson R; Rule J; Smith DE; de Wit J; Carr A; Siefried KJ, 2019, 'STI incidence and risk factors in HIV-infected adults on antiretrovrial therapy (ART) in the PAART study', Perth, Australia, presented at Joint Australasian Sexual Health and HIV&AIDS Conference, Perth, Australia, 16 September 2019 - 19 September 2019
    Conference Posters | 2019
    Ezard N; Dunlop AJ; Clifford B; Bruno R; Siefried KJ; Carr A; Lintzeris N, 2019, 'Safety of oral lisdexamfetamine in adults with methamphetamine dependence: a dose-escalating phase-2 study', San Antonio, Texas, USA, presented at The College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, Texas, USA, 15 June 2019 - 19 July 2019
    Conference Abstracts | 2019
    Templeton DJ; Poynten IM; Jin F; Roberts JM; Law CLH; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2019, 'The natural history of anal high grade squamous intraepithelial lesions in HIV positive and HIV negative gay and bisexual men', in HIV MEDICINE, WILEY, Vol. 20, pp. 18 - 18,
    Conference Posters | 2019
    Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019,
    Conference Posters | 2018
    Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (updated report with predictors of ART failure)', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018
    Conference Posters | 2018
    Siefried KJ; Mao L; Riches S; Kerr S; Rule J; de Wit J; Carr A, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (an updated report with predictors of ART failure)', Sydney, Australia, presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018
    Conference Presentations | 2018
    Siefried KJ; Mao L; Rule J; de Wit J; Carr A, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018
    Conference Posters | 2018
    Siefried KJ; Mao L; Rule J; de Wit J; Carr A, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018
    Theses / Dissertations | 2018
    Siefried KJ, 2018, Antiretroviral therapy and treatment cascade outcomes in a cohort of adults living with HIV in Australia
    Conference Abstracts | 2017
    Bruno R; Ezard N; Dunlop AJ; Clifford B; Carr A; Lintzeris N, 2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23,
    Conference Papers | 2017
    Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017,
    Conference Posters | 2017
    Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
    Conference Presentations | 2017
    Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', presented at The Australasian HIV&AIDS Conference, Canberra Australia, 06 November 2017 - 08 November 2017
    Conference Posters | 2017
    Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Canberra, Australia, presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017
    Conference Papers | 2017
    Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017,
    Conference Posters | 2017
    Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
    Conference Papers | 2017
    Siefried KJ; Mao L; Riches R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017,
    Conference Presentations | 2017
    Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017
    Conference Posters | 2017
    Siefried KJ; Mao L; Riches S; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
    Conference Posters | 2017
    Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017,
    Conference Abstracts | 2016
    Chen W; Carr A; Center J; Pocock N, 2016, 'EFFECT OF SWITCH FROM TENOFOVIR TO RALTEGRAVIR ON TRABECULAR BONE SCORE', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, SINGAPORE, Singapore, Vol. 27, pp. S725 - S725, presented at IOF-Regionals 6th Asia-Pacific Osteoporosis Meeting, SINGAPORE, Singapore, 04 November 2016 - 06 November 2016,
    Conference Abstracts | 2016
    Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36,
    Conference Papers | 2016
    Siefried KJ; Mao L; Kerr S; Gates T; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART study', in Antiviral Therapy, International Medical Press, New York City, USA, presented at The 18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, New York City, USA, 12 September 2016 - 13 September 2016
    Conference Presentations | 2016
    Siefried KJ; Mao L; Kerr S; Gates T; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced adults: data from the PAART study', presented at The Australasian HIV&AIDS Conference, Adelaide, Australia, 16 November 2016 - 18 November 2016
    Conference Abstracts | 2016
    Siefried KJ; Mao L; Kerr S; Gates TM; Maynard A; Cysique LA; McAllister J; de Wit J; Carr A, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016,
    Conference Abstracts | 2016
    Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman R; Grulich A; Kelleher A; Carr A, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016,
    Conference Abstracts | 2015
    Sasson SC; McGill K; Weinholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24,
    Conference Presentations | 2015
    Siefried KJ; Mao L; Kerr S; Gates T; Cysique LA; de Wit J; Carr A, 2015, 'Parameters associated with adherence to antiretroviral therapy in HIV-infected Australian adults: the PAART study', presented at The Australasian HIV&AIDS Conference, Brisbane, Australia, 16 September 2015 - 18 September 2015
    Conference Abstracts | 2015
    Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168,
    Conference Posters | 2015
    Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015
    Conference Posters | 2014
    Siefried KJ; McAllister J; McNulty A; Read TR; Pearce A; Richardson R; Carr A, 2014, 'Safety and tolerability of, and adherence to, co-formulated emtricitabine-rilpivirine-tenofovir used as HIV non-occupational post-exposure prophylaxis in men who have sex with men', Sydney, Australia, presented at The St Vincent’s and Mater Health Research Symposium, Sydney, Australia, 11 September 2014 - 11 September 2014
    Conference Papers | 2014
    Tong WWY; Bloch M; Hoy J; Baker D; Richardson R; Carr A, 2014, 'Changes in bone mineral density and markers of bone turnover over 96 weeks after switching from tenofovir to raltegravir', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A35 - A35, presented at 16th International Workshop on Co-Morbidities and Adverse Drug Reaction in HIV, PA, Philadelphia, 06 October 2014 - 08 October 2014,
    Conference Posters | 2013
    Siefried KJ; Mao L; McAllister J; Richardson R; Watson J; de Wit J; Carr A, 2013, 'Predictors of adherence to antiretroviral therapy in HIV-infected adults (the PAART pilot study)', Darwin, Australia, presented at The Australasian HIV&AIDS Conference, Darwin, Australia, 21 October 2013 - 23 October 2013
    Conference Abstracts | 2012
    Peacock A; Bruno R; Martin F; Carr A, 2012, 'PERCEPTION OF INTOXICATION FOLLOWING ALCOHOL AND ENERGY DRINK CONSUMPTION', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 31, pp. 13 - 13,
    Conference Papers | 2011
    Ebeling PR; Haskelberg H; Hoy J; Amin J; Emery S; Carr A, 2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, AUSTRALIA, Gold Coast, 04 September 2011 - 08 September 2011,
    Conference Papers | 2010
    Bloch M; Martin A; Amin I; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Conference Papers | 2010
    Bloch M; Martin A; Amin J; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Conference Papers | 2010
    Cysique LA; Myung-Lee J; Lane T; Moffat K; Davies N; Carr A; Brew BJ; Rae C, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, ITALY, Milan, 12 October 2010 - 16 October 2010,
    Conference Papers | 2010
    Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Conference Papers | 2010
    Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Conference Papers | 2009
    Distler O; Mallon PW; Kelleher AD; Carr A; Calmy A; Cooper DA, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009,
    Conference Papers | 2008
    Currier JS; Lundgren JD; Carr A; Klein D; Sabin CA; Sax PE; Schouten JT; Smieja M, 2008, 'Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy', in Circulation,
    Conference Papers | 2008
    Grund B; Peng G; Isaksson R; Ellis K; Gilbert C; Shlay J; Drummond F; Martinez E; Hoy JF; Reiss P; El-Sadr W; Thomas A; Visnegarwala F; Carr AD, 2008, 'Continuous antiretroviral therapy decreases bone mineral density: results from the SMART study', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. A26 - A26, presented at Antiviral Therapy, London, ENGLAND,
    Conference Papers | 2006
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A, 2006, 'Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006,
    Conference Papers | 2006
    Wand H; Calmy A; Carey D; Samaras K; Carr A; Law M; Cooper D; Emery S, 2006, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006,
    Conference Papers | 2004
    Carr A, 2004, 'HIV drug adverse events: Selected highlights from the 15th International AIDS Conference', in HIV Clinical Trials, pp. 252 - 256,
    Conference Papers | 2003
    Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
    Conference Papers | 2003
    Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
    Conference Papers | 2002
    Amin J; Carr A; Hill A; Emery S; Law M; Cooper DA, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002,
    Conference Papers | 2002
    Mallon PWG; Munier ML; McGhie K; Zaunders J; Kelleher A; Cooper DA; Carr A, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002,
    Conference Papers | 2002
    Puls RL; Law M; Freund J; Gallagher D; Punyanitya M; Kalnins S; Carr A, 2002, 'The effect of centralized body composition data analysis on an objective case definition of HIV lipodystrophy', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L53 - L53, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002,
    Conference Papers | 1994
    Imrie A; Carr AD; Duncombe CJ; Finlayson R; Vizzard J; Law MG; Kaldor JM; Penny R; Cooper DA, 1994, 'Primary infection with Zidovudine-resistant human immunodeficiency virus type 1 does not adverseley affect outcome at 1 year', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, presented at International Workshop on HIV drug resistance, Hawaii
    Conference Papers | 1993
    Carr A; Penny R, 1993, 'Roundtable discussion: Management issues in didanosine therapy', in Journal of Acquired Immune Deficiency Syndromes, pp. S51 - S55